摘要:
Provided is a prophylactic/therapeutic agent for influenza viral infection that is effective not only before and at an early stage of infection with influenza virus but also at an intermediate or late stage of the infection and is highly safe for human bodies. A prophylactic/therapeutic drug for influenza viral infection comprising, as active ingredients, 5-aminolevulinic acid (5-ALA), a derivative thereof or a salt of the 5-ALA or the derivative, and an iron compound is prepared. This prophylactic/therapeutic agent can be used for ameliorating (preventing) depression in food consumption, water consumption and body weight, for ameliorating (decreasing) increase in ketone body levels in blood that may otherwise cause ketosis, for ameliorating (preventing) depression in ATP levels in blood, or for ameliorating (increasing) a survival rate and depression in a body surface temperature.
摘要:
Problem to be Solved A prophylactic and/or therapeutic agent for side effects of anticancer agent is provided. Solution The present invention provides a prophylactic and/or therapeutic agent for side effects of anticancer agent comprising ALAs.
摘要:
The object of the present invention to provide an agent effective for treating and preventing e.g. a disease caused by reduction in frataxin production. The present invention provides a frataxin enhancer comprising 5-aminolevulinic acid (ALA) or a derivative thereof or salts thereof, as well as a therapeutic and/or prophylactic agent for a disease caused by reduction in frataxin production.
摘要:
Provided is an enhancer for cancer thermotherapy not combined with photodynamic therapy. Cancer treatment not combined with photodynamic therapy is made available by using, as an enhancer for cancer thermotherapy, 5-aminolevulinic acids represented by formula (1):
R 2 R 1 NCH 2 COCH 2 CH 2 COR 3 (1)
[wherein R 1 and R 2 each independently represent a hydrogen atom, an alkyl group, an acyl group, an alkoxycarbonyl group, an aryl group, or an aralkyl group; and R 3 represents a hydroxy group, an alkoxy group, an acyloxy group, an alkoxycarbonyloxy group, an aryloxy group, an aralkyloxy group, or an amino group] or a salt thereof.
摘要翻译:提供了不与光动力疗法结合的癌症热疗的增强剂。 通过使用作为癌症热疗的增强剂,通过式(1)表示的5-氨基乙酰丙酸可以获得不与光动力疗法组合的癌症治疗:€ƒ€ƒ€ƒ€ƒ€ƒ€ƒR2 R 1 NCH 2 COCH 2 CH 2 COR 3€ƒ€ƒ€ƒ(1)[其中R 1和R 2各自独立地表示氢原子,烷基,酰基,烷氧基羰基,芳基 ,或芳烷基; R 3表示羟基,烷氧基,酰氧基,烷氧基羰氧基,芳氧基,芳烷氧基或氨基]或其盐。
摘要:
Problem to be Solved The present invention provides a therapeutic agent and/or prophylactic agent for renal anemia. The present invention also provides an erythropoietin production promoter. Solution The present invention provides a therapeutic and/or prophylactic agent for renal anemia comprising ALAs. The present invention also provides an erythropoietin production promoter comprising ALAs.
摘要:
A stem cell removing method that certainly-removes an undifferentiated stem cell is provided. For this object, a cell group including a stem cell and a somatic cell performed differentiation induction is cultivated in culture medium composition including photosensitizer. Light of a specific wavelength is irradiated with the cell group, and the stem cell is removed, selectively. The stem cell is a pluripotent stem cell or a somatic stem cell. The pluripotent stem cell includes either an ES cell (Embryonic Stem Cell) or an iPS cell (induced Pluripotent Stem Cell). Also, somatic stem cell includes any one of a germ stem cell, a productive cell, a pluripotent stem cell and a stem cell having unipotency.
摘要:
To provide a diagnostic agent for mitochondrial dysfunction brain diseases including cerebral infarction as a representative. A diagnostic agent for a mitochondrial dysfunction brain disease, which comprises (A) ´-aminolevulinic acid represented by the formula (1), a derivative thereof, or a salt thereof and (B) an iron compound in combination. €ƒ€ƒ€ƒ€ƒ€ƒ€ƒ€ƒ€ƒ R 2 R 1 NCH 2 COCH 2 CH 2 COR 3 €ƒ€ƒ€ƒ€ƒ€ƒ(1) wherein R 1 and R 2 each independently represents a hydrogen atom, an alkyl group, an acyl group, an alkoxycarbonyl group, an aryl group, or an aralkyl group; and R 3 represents a hydroxy group, an alkoxy group, an acyloxy group, an alkoxycarbonyloxy group, an aryloxy group, an aralkyloxy group, or an amino group.
摘要:
An object of the present invention is to provide a PDD diagnosis apparatus that even if there is a distance from an irradiation portion of an optical fiber to a diseased tissue, enables provision of a fluorescence detection sensitivity equivalent to that in a case where irradiation is provided in such a manner that the irradiation portion of the optical fiber is brought close to the diseased tissue. A diagnosis apparatus including: a light source unit that emits excitation light to a photosensitizing substance accumulated in a diseased tissue; a detection unit that detects fluorescence produced from the photosensitizing substance; and an excitation light irradiation/fluorescence detection optical fiber including an output/input end with a collimator connected thereto, in which the excitation light emitted from the light source unit is guided to the excitation light irradiation/fluorescence detection optical fiber, and the excitation light output from the output/input end is provided in such a manner that the excitation light is collimated by the collimator and excites the photosensitizing substance accumulated in the diseased tissue; and the fluorescence produced by the photosensitizing substance excited by the excitation light is input from the output/input end via the collimator, and the input fluorescence is guided to the excitation light irradiation/fluorescence detection optical fiber and the fluorescence produced from the photosensitizing substance is detected in the detection unit is used.